Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.
暂无分享,去创建一个
V. Uversky | Jie Li | A. Fink | V N Uversky | A L Fink | J Li | J. Li
[1] V. Uversky,et al. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. , 2001, Biochemistry.
[2] R. Duvoisin. A brief history of parkinsonism. , 1992, Neurologic clinics.
[3] M. Hosokawa,et al. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.
[4] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[5] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[6] L. Mucke,et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.
[7] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[9] V. Uversky,et al. Effect of self-association on the structural organization of partially folded proteins: inactivated actin. , 1999, Biophysical journal.
[10] L. Forno,et al. Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.
[11] P D Griffiths,et al. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.
[12] M. Roy,et al. Facteurs environnementaux dans l'étiologie de la maladie de Parkinson , 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[13] P. Riederer,et al. Iron in brain function and dysfunction with emphasis on Parkinson's disease. , 1991, European neurology.
[14] Takeshi Iwatsubo,et al. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia , 1998, Cell Death and Differentiation.
[15] Gregory G. Brown,et al. Occupational exposures to metals as risk factors for Parkinson's disease , 1997, Neurology.
[16] M. Citron,et al. alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. , 1999, The Journal of biological chemistry.
[17] A. Fink,et al. Acid-induced folding of proteins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Matulis,et al. 1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation. , 1998, Biophysical journal.
[19] P. Lansbury,et al. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.
[20] George B. Benedek,et al. Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .
[21] C. Hertzman,et al. A case‐control study of Parkinson's disease in a horticultural region of British Columbia , 1994, Movement disorders : official journal of the Movement Disorder Society.
[22] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[23] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[24] P. Lansbury,et al. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.
[25] C. C. Johnson,et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. , 1999, Neurotoxicology.
[26] David F. Clayton,et al. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.
[27] Peter Riederer,et al. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.
[28] E. Montgomery. Heavy metals and the etiology of Parkinson's disease and other movement disorders. , 1995, Toxicology.
[29] V. Uversky,et al. Association of partially‐folded intermediates of staphylococcal nuclease induces structure and stability , 2008, Protein science : a publication of the Protein Society.
[30] C. W. Olanow,et al. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.
[31] A. Bush,et al. Metals and neuroscience. , 2000, Current opinion in chemical biology.
[32] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[33] D. Eliezer,et al. Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.
[34] P. James,et al. Anoxic Asphyxia – a Cause of Industrial Fatalities: A Review , 1991, Journal of the Royal Society of Medicine.
[35] Michel Goedert,et al. Identification of two distinct synucleins from human brain , 1994, FEBS letters.
[36] A. Fink,et al. Conformational states of beta-lactamase: molten-globule states at acidic and alkaline pH with high salt. , 1989, Biochemistry.
[37] R. Jakes,et al. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's disease , 1998, FEBS letters.
[38] A. Fink. Compact intermediate states in protein folding. , 1995, Annual review of biophysics and biomolecular structure.
[39] M Yasui,et al. Calcium, magnesium and aluminum concentrations in Parkinson's disease. , 1992, Neurotoxicology.
[40] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[41] R. Scheller,et al. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[42] H. Naiki,et al. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[43] J. Trojanowski,et al. Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro * , 1999, The Journal of Biological Chemistry.
[44] C. Olanow,et al. Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study , 1994, Brain Research.
[45] C. Tanner,et al. The role of environmental toxins in the etiology of Parkinson's disease , 1989, Trends in Neurosciences.
[46] A J McLean,et al. Pesticides and Parkinson's disease. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[47] R. Wetzel. For Protein Misassembly, It's the “I” Decade , 1996, Cell.
[48] H. Vinters,et al. Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence† , 1996 .
[49] D. Kirschner,et al. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[50] P. Lansbury,et al. Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. , 1992, Biochemistry.
[51] E. Altschuler,et al. Aluminum-containing antacids as a cause of idiopathic Parkinson's disease. , 1999, Medical hypotheses.
[52] V. Tennyson,et al. Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease , 1965 .
[53] J W Langston,et al. Parkinson disease in twins: an etiologic study. , 1999, JAMA.
[54] R. Anthony Crowther,et al. Synthetic filaments assembled from C‐terminally truncated α‐synuclein , 1998 .
[55] O. Ptitsyn,et al. Molten globule and protein folding. , 1995, Advances in protein chemistry.
[56] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[57] C. C. Johnson,et al. Parkinson's disease mortality and the industrial use of heavy metals in Michigan , 1993, Movement disorders : official journal of the Movement Disorder Society.
[58] Michel Goedert,et al. Familial Parkinson's disease: The awakening of α-synuclein , 1997, Nature.
[59] N. A. Rodionova,et al. Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe , 1991, Biopolymers.
[60] C D Marsden,et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.
[61] K. Jellinger,et al. The role of transition metals in the pathogenesis of Parkinson's disease , 1995, Journal of the Neurological Sciences.
[62] V. Uversky,et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.
[63] M. Eftink,et al. Fluorescence quenching studies with proteins. , 1981, Analytical biochemistry.
[64] A. Fink,et al. Classification of acid denaturation of proteins: intermediates and unfolded states. , 1994, Biochemistry.
[65] Y. Agid,et al. Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis , 1991, Journal of neurochemistry.
[66] J Kim,et al. Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid. , 1997, Archives of biochemistry and biophysics.
[67] Ken A. Dill,et al. Aggregation of globular proteins , 1993 .
[68] S Doniach,et al. Association-induced folding of globular proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[69] V. Uversky,et al. Why are “natively unfolded” proteins unstructured under physiologic conditions? , 2000, Proteins.
[70] L. Stryer,et al. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. , 1965, Journal of molecular biology.
[71] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[72] M. Citron,et al. Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.